Clinical evaluation of a new antihistamine, buclizine hydrochloride (vibazine).
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006967:Hypersensitivity / Q000628:therapy*; D010879:Piperazines
D018926:Anti-Allergic Agents; D006634:Histamine H1 Antagonists; D010879:Piperazines; C046894:buclizine
ALLERGY/therapy; ANTIHISTAMINICS/therapeutic use